Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | ZTS | TAK | UTHR | STVN |
| Company | Neurocrine Bioscienc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Stevanato Group S.P.A. |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 112.41 | 190.21 | 14.12 | 355.62 | 18.37 |
| High | 116.29 | 192.82 | 14.31 | 358.82 | 19.25 |
| Low | 112.16 | 189.70 | 14.11 | 354.00 | 18.00 |
| Last | 115.49 | 190.08 | 14.30 | 358.22 | 19.00 |
| Change | +3.08 | -0.20 | -0.01 | +3.89 | +0.68 |
| % Change | +2.74% | -0.11% | -0.07% | +1.10% | +3.71% |
| Volume | 781,000 | 1,819,900 | 3,156,000 | 160,200 | 1,172,000 |
| 20-Day Average Volume | 823,530 | 1,759,585 | 1,965,025 | 338,710 | 547,030 |
| Previous Close | 112.41 | 190.28 | 14.31 | 354.33 | 18.32 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 115.78 | 192.46 | 14.53 | 353.79 | 19.57 |
| 20-Day Raw Stochastic | 35.97% | 25.13% | 22.75% | 82.17% | 24.81% |
| 20-Day Relative Strength | 39.12% | 51.87% | 45.71% | 57.13% | 45.41% |
| Weighted Alpha | -8.04 | +10.88 | -2.34 | +62.42 | -42.60 |
| Today's Opinion | 100% Sell | 80% Buy | 24% Buy | 100% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 80% Buy | 40% Buy | 100% Buy | 88% Sell |
| Last Month's Opinion | 40% Sell | 88% Buy | 72% Buy | 88% Buy | 80% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.31% since 10/04/24 | +0.03% since 10/04/24 | -0.90% since 10/04/24 | +0.64% since 10/04/24 | +0.16% since 10/04/24 |
| Low | 110.99 on 10/08/24 | 186.64 on 10/07/24 | 14.11 on 10/11/24 | 346.31 on 10/07/24 | 18.00 on 10/11/24 |
| High | 116.29 on 10/11/24 | 192.82 on 10/11/24 | 14.43 on 10/07/24 | 358.97 on 10/07/24 | 19.35 on 10/07/24 |
| 1-Month | |||||
| %Chg | -4.92% since 09/11/24 | +0.05% since 09/11/24 | -3.51% since 09/11/24 | +3.47% since 09/11/24 | -5.94% since 09/11/24 |
| Low | 110.95 on 10/03/24 | 186.64 on 10/07/24 | 14.11 on 10/11/24 | 337.52 on 09/13/24 | 18.00 on 10/11/24 |
| High | 123.57 on 09/16/24 | 200.33 on 09/19/24 | 14.94 on 09/17/24 | 362.52 on 09/26/24 | 22.03 on 09/27/24 |
| 3-Month | |||||
| %Chg | -21.17% since 07/11/24 | +6.94% since 07/11/24 | +6.72% since 07/11/24 | +10.60% since 07/11/24 | -9.31% since 07/11/24 |
| Low | 110.95 on 10/03/24 | 172.24 on 08/05/24 | 13.24 on 07/19/24 | 310.00 on 07/31/24 | 17.94 on 08/06/24 |
| High | 157.98 on 08/01/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 23.20 on 08/29/24 |
| 6-Month | |||||
| %Chg | -15.04% since 04/11/24 | +16.81% since 04/11/24 | +5.30% since 04/11/24 | +50.99% since 04/11/24 | -34.48% since 04/11/24 |
| Low | 110.95 on 10/03/24 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 230.39 on 04/16/24 | 16.56 on 06/25/24 |
| High | 157.98 on 08/01/24 | 200.33 on 09/19/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 29.81 on 04/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,622,568 | 86,732,560 | 45,257,168 | 15,889,204 | 5,615,260 |
| Shares Outstanding, K | 100,637 | 456,295 | 3,164,837 | 44,356 | 295,540 |
| Annual Sales | 1,887,100,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,174,680,000 |
| Annual Net Income | 249,700,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 157,620,000 |
| Last Quarter Sales | 590,200,000 | 2,361,000,000 | 7,731,140,000 | 714,900,000 | 279,540,000 |
| Last Quarter Net Income | 65,000,000 | 624,000,000 | 609,590,000 | 278,100,000 | 22,210,000 |
| 60-Month Beta | 0.36 | 0.89 | 0.54 | 0.57 | 0.57 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.63 on 08/01/24 | 1.56 on 08/06/24 | 0.56 on 07/31/24 | 5.85 on 07/31/24 | 0.10 on 08/06/24 |
| Latest Earnings Date | 10/30/24 | 11/04/24 | 10/24/24 | 11/06/24 | 10/29/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 10/31/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 34.89 | 34.31 | 9.11 | 16.46 | 35.19 |